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ABSTRACT 
This study aims to determine the cross-reaction between the antigen of avian influenza (AI) H5N1 virus clades 
2.1.3 and 2.3.2 in duck and chicken sera, which were vaccinated with inactivated AI H5N1 clade 2.1.3 vaccine 
against AI H5N1 clade 2.3.2 antigen and those vaccinated with inactivated AI H5N1 clade 2.3.2 vaccine 
against H5N1 clade 2.1.3 antigen. The sera tested were obtained from postvaccination and control 
(unvaccinated) chickens and ducks in the laboratory condition, and from AI H5N1 postvaccination ducks in the 
field condition. HI test was conducted by using AI H5N1 clades 2.1.3 and 2.3.2 antigens. The results of HI titer 
were analyzed by the geometric means and by ANOVA. The results show that cross-reactions in both chicken 
and duck sera after AI H5N1 clade 2.3.2 vaccination tested with AI H5N1 clade 2.1.3 antigen occurred with 
low antibody titers, whereas in chicken and duck sera postvaccination with avian influenza H5N1 virus clade 
2.1.3 showed cross-reaction with high antibody titer against clade 2.3.2 antigen. The conclusion of this study, 
postvaccination sera of AI H5N1 clade 2.1.3 provide better cross-reaction compared to the postvaccination sera 
of AI H5N1 clade 2.3.2. 
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ABSTRAK 
Studi ini bertujuan menentukan reaksi silang antara antigen (virus) avian influenza (AI) H5N1 clade 2.1.3 dan 
2.3.2 di dalam serum ayam dan itik yang divaksinasi dengan vaksin inaktif AI H5N1 clade 2.1.3 terhadap 
antigen AI H5N1 clade 2.3.2 dan yang divaksinasi dengan vaksin inaktif AI H5N1 clade 2.3.2 terhadap antigen 
H5N1 clade 2.1.3. Serum uji diperoleh dari serum ayam dan itik coba pascavaksinasi dan kontrol (tidak 
divaksinasi) pada kondisi laboratorium dan serum itik lapang pascavaksinasi AI H5N1. Uji HI dilakukan 
dengan menggunakan antigen AI H5N1 clade 2.1.3 dan clade 2.3.2. Analisa hasil titer HI dilakukan dengan 
geometric means dilanjutkan dengan ANOVA. Hasil uji HI menunjukkan reaksi silang baik serum ayam 
maupun itik pascavaksinasi AI H5N1 clade 2.3.2 dengan antigen clade 2.1.3 terjadi dengan titer antibodi 
rendah, sedangkan serum ayam mupun serum itik pascavaksinasi AI H5N1 clade 2.1.3 menunjukan reaksi 
silang dengan titer antibodi tinggi terhadap antigen AI H5N1 clade 2.3.2. Simpulan dari studi ini, serum 
pascavaksinasi dengan vaksin AI H5N1 clade 2.1.3 memberikan reaksi silang lebih baik dibandingkan dengan 
serum pascavaksinasi  dengan vaksin AI H5N1 clade 2.3.2.    
 
Kata Kunci: serum, ayam, itik, AI H5N1, clade 2.1.3 dan clade 2.3.2.  
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INTRODUCTION 
 
Avian influenza (H5N1) virus has spread 
to several countries in the world and caused a 
high mortality especially in poultry (Zessin, 
2007). The H5N1 clade 2.1.3 virus, which 
causes many deaths in chickens and is 
economically disadvantageous, was firstly 
detected in Indonesia at the end of 2003 
(Dharmayanti et al. 2004; Wiyono et al. 2004). 
From September to November  2012, there 
were many deaths of ducks in Central Java, 
Jogjakarta and East Java Provinces caused by 
AI H5N1 clade 2.3.2 virus (Wibawa et al. 
2012). Wibawa et al. (2012) also reported that 
the AI H5N1 clade 2.3.2 virus is not a 
descendant of the AI H5N1 clade 2.1.3 virus in 
Indonesia, based on a low homology rate (91-
93%) compared to viruses from clade 2.1.3. 
Poultry (chickens and ducks) vaccinated 
with  AI H5N1 can be avoided from the 
possibility of getting infected by the existing 
AI H5N1 field virus by either clade 2.1.3 or 
2.3.2 (Indriani et al. 2014; Indriani & 
Dharmayanti 2015). The vaccine provides a 
high protective immune response generated by 
hemagglutinin (HA) and a small amount of 
neuraminidase (NA) present in the vaccine 
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antigen (WHO, 2002). Postvaccination immune 
responses in poultry can be measured by 
hemaglutination inhibition (HI) test (OIE, 
2012). The current available AI H5N1 vaccines 
in the market are the AI H5N1 clades 2.1.3 and 
2.3.2 vaccines (Ditjen PKH 2014). A study of 
the cross-reaction levels of AI H5N1 clades 
2.1.3 and 2.3.2 vaccines in chicken and duck 
were carried out and discussed in this paper. 
 
MATERIALS AND METHODS 
 
Sera were obtained from groups of 
chickens and ducks vaccinated with AI H5N1 
clades 2.1.3 and 2.3.2 in the laboratory (BB 
Litvet) and from ducks vaccinated with AI 
H5N1 vaccine in the field (farms).  
The 3-week spesific pathogenic free (SPF) 
chickens were divided into 3 groups consisting 
of 20 chickens each namely; (1) vaccinated with 
inactivated AI H5N1 clade 2.1.3 vaccine, (2) 
vaccinated with inactivated AI H5N1 clade 
2.3.2 vaccine and (3) unvaccinated (as the 
control). Three-week old local ducks (maternal 
AI H5N1 antibodies was negative) were divided 
into 3 groups of 20 each i.e.: (1) vaccinated with 
inactivated AI H5N1 clade 2.3.2 vaccine, (2) 
vaccinated with inactivated AI H5N1 clade 
2.1.3 vaccine and (3) unvaccinated (as the 
control). Furthermore, the sera of six-week old 
chickens and ducks (3 weeks postvaccination) 
from each group were collected to be tested 
with HI test using AI H5N1 clade 2.1.3 and 
2.3.2 antigens to detect antibodies prevaccination 
and postvaccination.  
Forty sera from ducks vaccinated with AI 
H5N1 of unknown clade obtained from fields 
were tested with HI test using AI H5N1 clade 
2.1.3 and 2.3.2 antigens to detect the antibody. 
Preparing AI H5N1 clades 2.1.3 and 2.3.2 
antigens 
The antigen for HI test was prepared from the 
AI H5N1 virus clade 2.3.2: A/duck/Sukoharjo/
BBVW-1428-9 /2012 (BBVet-Wates-Jogja) and 
the AI H5N1 virus clade 2.1.3: A/Ck/Wj/PWT-
Wij/2006 (BB Litvet). Each virus was 
propagated in the eleven-day old SPF eggs and 
inactivated with B-propiolacton by a ratio of 1: 
2000 (Indriani and Dharmayanti, 2015).  
Hemaglutination Inhibition (HI) Test 
Before being used, the trial chicken and 
duck sera were inactivated for an hour at 56°C 
to remove specific inhibitors (Pedersen, 2008 
and OIE, 2012) and duck sera were absorbed by 
red blood cells (RBC) to remove non-specific 
agglutinin (sometimes causing non-specific 
agglutination of chicken RBC) or to eliminate 
non-specific inhibitors of hemagglutination 
(Pedersen, 2008; OIE, 2012; WHO, 2002) prior 
to HI test. Briefly, a total of 25 μL of duck 
serum and 25 μL of 10% chicken RBC in PBS 
(OIE, 2012) in a V type microplate, incubated at 
4 ° C for 1 hour and centrifuged at 800 g for 5 
minutes to separate RBC. Around 25 μL was 
transferred into the first hole of a microplate 
containing 25 μL PBS. The duck and chicken 
sera were diluted at 1: 2and at 1:1respectively, 
thus the minimum detectable titers were 4 (2 
log2) and 2 (1 log2) for the duck and chicken 
sera respectively. HI test was performed with 
1% chicken RBC in PBS and used 4 
hemaglutination units (HAU) antigen (OIE, 
2012).  
HI titers are expressed as reciprocal values 
of the highest serum dilution causing the 
complete inhibition of agglutination of 4 HAU 
antigens. HI titer of 16 (4 log2) is classified as 
positive for avian influenza antibodies, 
according to OIE guidelines (2012). HI test 
procedures follow OIE (2012) and INDRAINI 
et al. (2004). 
HI test results were calculated by the 
geometric means titer (GMT) and analyzed by 
ANOVA for the significance (P <0.05). 
 
RESULTS  
 
The sera of chickens vaccinated with 
inactivated AI H5N1 clade 2.1.3 against AI 
H5N1 clade 2.1.3 antigen shows an average titer 
of 5.6 log2 with confidence interval (CI) of 5.1 
– 6. The cross-reaction against AI H5N1 clade 
2.3.2 antigen shows an average titer of 4.9 log2 
with CI of 4.3 - 5.3 (Figure 1). The sera of 
chickens vaccinated with inactivated AI H5N1 
clade 2.3.2 vaccine against AI H5N1 clade 2.3.2 
antigen shows an average titer of 6.8 log2 with a 
CI of 6.2 – 7.4, and the cross-reaction against 
AI H5N1 clade 2.1.3 antigen shows an average 
antibody titer of 2.8 log2 with CI of 2.4 – 3.2. 
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Meanwhile, the serum of unvaccinated SPF 
chickens shows a negative antibody titer against 
both AI H5N1 clades 2.1.3 and 2.3.2 antigens 
(Figure 1).  
The sera of chickens vaccinated with AI 
H5N1 clade 2.1.3 and those sera of chickens 
vaccinated with AI H5N1 clade 2.3.2 show 
cross-reactions with AI H5N1 clade 2.1.3 and 
clade 2.3.2 antigens. HI test results show that 
the highest chicken anitbody titer occurred 
when sera were tested with homologous antigen 
(vaccine antigen is the same with HI test 
antigen). The cross-reaction titer showed 
significant different (p <0.05) between the sera 
of chickens vaccinated with AI H5N1 clade 
2.1.3 against clade 2.3.2 antigen and the sera of 
chickens vaccinated with AI H5N1 clade 2.3.2  
againts clade  2.1.3 antigen. 
The sera of ducks vaccinated with 
inactivated AI H5N1 clade 2.1.3 against AI 
H5N1 clade 2.1.3 antigen shows an average titer 
of 4.4 log2 with confidence interval (CI) of 3.7 
– 5,1. The cross-reaction against AI H5N1 clade 
2.3.2 antigen shows an average titer of 3.5 log2 
with CI of 2.9 - 4 (Figure 2). 
The sera of ducks vaccinated with 
inactivated AI H5N1 clade 2.3.2 vaccine against 
AI H5N1 clade 2.3.2 antigen shows an average 
antibody titer of 4,7 log2 with  CI of 4-5, and 
the cross-reaction against AI H5N1 clade 2.1.3 
antigen does not show the presence of the 
antibody (negative titer). The unvaccinated duck 
sera shows negative antibody titer against both 
AI H5N1 clades 2.1.3 and 2.3.2 antigens 
(Figure 2). The cross-reaction titer showed 
significant different (p <0.05) between the sera 
of ducks vaccinated with AI H5N1 clade 2.1.3 
against clade 2.3.2  antigens and the sera of 
ducks vaccinated with AI H5N1 clade 2.3.2  
againts clade  2.1.3 antigen. 
The antibody titer is influenced by the type 
of vaccine and antigen, the sera of chickens and 
ducks vaccinated with AI H5N1 show positive 
antibodies, while the control chickens 
(unvaccinated) sera shows a negative titer  
The HI test results of sera collected from 
vaccinated ducks show the highest titer when 
tested with homologous antigen. The cross-
reaction titers from the HI test show a 
significant difference (p <0.05) between the titer 
of the ducks vaccinated with AI H5N1 clade 
2.1.3 against clade 2.3.2 antigen and the ducks 
vaccinated with AI H5N1 clade 2.3.2 against 
clade 2.1.3 antigen. 
The HI test results of sera collected from 
vaccinated ducks show that the highest titer 
obtained when being tested with homologous 
antigen. The cross-reaction antibody titers from 
the HI test show a significant difference (p 
<0.05) between the titer of the ducks vaccinated 
with AI H5N1 clade 2.1.3 against clade 2.3.2 
antigen and the ducks vaccinated with AI H5N1 
clade 2.3.2 against clade 2.1.3 antigen.  
The titer of field duck sera vaccinated with 
AI H5N1 vaccine tested against the AI H5N1 
clade 2.1.3 antigen shows an average antibody 
titer of 4.3 log2 with CI of 3.5 - 5, and the cross
Figure 1. HI test results of chicken sera vaccinated 
with AI H5N1 clades 2.1.3 and 2.3.2 against AI 
H5N1 clade 2.1.3 and 2.3.2 antigens   
Figure 2. HI test results of duck sera vaccinated 
with AI H5N1 clade 2.3.1  and 2.3.2 against AI 
H5N1 clade 2.1.3 and 2.3.2 antigen.  
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-reaction titer against AI H5N1 clade 2.3.2 
antigen shows an average antibody titer of 3.1 
log2 with CI of 2.5 - 3.7 (Figure 3). The HI test 
results of field ducks vaccinated with AI H5N1 
vaccine show high antibody titers when tested 
with AI H5N1 clade 2.1.3 antigen and good 
cross-reaction against AI H5N1 clade 2.3.2 
antigen (Figure 3). 
 
DISCUSSION 
 
The avian influenza (AI) H5N1 clades 
2.1.3 and 2.3.2 virus is highly pathogenic in 
poultry (OIE, 2013). Chickens and ducks 
infected by these viruses can result in illness 
and death. Vaccination can prevent ducks and 
chickens from H5N1 virus clades 2.1.3 and 
2.3.2 infection, so that chickens or ducks have 
immunity by forming antibody against AI 
H5N1 viruses clades 2.1.3 and 2.3.2. Antibody 
titers in chicken and duck sera can be measured 
by HI test. The results of this study show that 
the antibody of ducks and chickens vaccinated 
with AI H5N1 clade 2.1.3 vaccine cross-reacts 
with AI H5N1 clade 2.3.2 antigen. This can be 
shown as presented by Indriani et al. (2014) and 
Indriani & Dharmayanti (2015); the protection 
level of Mojosari ducks and SPF chickens 
vaccinated with AI H5N1 clade 2.1.3 vaccine 
were 80% and 90% respectively against AI 
H5N1 virus clade 2.3.2 infection in the 
laboratory conditions, and the birds with the 
antibody titer of 6 log2 showed undetectable 
excretion of the infectious virus. This study also 
shows that chickens or ducks vaccinated with 
AI H5N1 clade 2.3.2 vaccinehad low cross-
reaction antibody titers against AI H5N1 clade 
2.1.3 antigen i.e. 2.8 log2 with CI of 2.4 – 3.2 in 
chickens and negative titer in ducks, which are 
still under the positive titer classified by OIE  (4 
log2) (OIE, 2012).  Sera of chicken and ducks 
vaccinated with AI H5N1 clade 2.1.3 against AI 
H5N1 clade 2.3.2  antigenhad better cross-
reaction compared to the sera of chickens and 
ducks vaccinated with AI H5N1 clade 2.3.2 
vaccine against antigen of AI H5N1 clade 2.1.3. 
This can provide an overview in the selection of 
AI H5N1 vaccine for the prevention of infection 
in duck and chickenpopulation in the field. Also, 
the AI H5N1 clade 2.1.3 antigen showed 
superior compared to clade 2.3.2 antigen 
indicated by higher cross-reaction pattern, 
suggesting that the antigen generated from AI 
H5N1 clade 2.3.2 virus is better for diagnostic 
test. This is in agreement with previous study by 
Ducates et al. (2011) in which the cross-
reactivity was evaluated for AI H5N1 clades 0, 
1, 2.1, 2.2, 2.3, and 4 viruses for the selection of 
a prospective diagnostic reagent for AI H5N1 
strains. 
The sera of field ducks had high antibody 
titers againts AI H5N1 clade 2.1.3 antigen and 
lower titer against AI H5N1 clade 2.3.2 antigen; 
this may indicate that the sera tested in this 
study were obtained from the ducks vaccinated  
with AI H5N1 clade 2.1.3 vaccine. 
 
CONCLUSION 
 
It can be concluded that the sera of 
chickens and ducks vaccinated with a single AI 
H5N1 clade 2.1.3 vaccine show cross-reactions 
with high HI titers against AI H5N1 clade 2.3.2 
antigen, compared to the sera of chickens and 
ducks  vaccinated with a single  AI H5N1 clade 
2.3.2 vaccine that show low HI titers against AI 
H5N1 clade 2.1.3 antigen. 
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Figure 3. HI test results of ducks sera of field 
ducks vaccinated with AIH5N1 against AI 
H5N1 clade 2.3.1 and 2.3.2 antigens    
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